ID22957A - Senyawa dan penggunaannya - Google Patents

Senyawa dan penggunaannya

Info

Publication number: ID22957A
Authority: ID; Indonesia
Prior art keywords: compound
Prior art date: 1998-06-10

Application number

IDP990201D

Other languages

English (en)

Inventor

Lorraine Mary Edmeades

Nigel Arthur Griffith-Skinner

Derek Anthony Hill

Graham Thronton Hill

Terence Williampackham

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-10

Filing date

1999-03-10

Publication date

1999-12-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10833464&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID22957(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-03-10 Application filed by Wellcome Found filed Critical Wellcome Found

1999-12-23 Publication of ID22957A publication Critical patent/ID22957A/id

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
- Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Analytical Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Physics & Mathematics (AREA)
Immunology (AREA)
Pathology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)
Plural Heterocyclic Compounds (AREA)
Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)

IDP990201D 1998-06-10 1999-03-10 Senyawa dan penggunaannya ID22957A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9812413.4A GB9812413D0 (en)	1998-06-10	1998-06-10	Compound and its use

Publications (1)

Publication Number	Publication Date
ID22957A true ID22957A (id)	1999-12-23

Family

ID=10833464

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDP990201D ID22957A (id)	1998-06-10	1999-03-10	Senyawa dan penggunaannya

Country Status (31)

Country	Link
US (1)	US6333198B1 (id)
EP (2)	EP0963980B1 (id)
JP (1)	JP2989189B1 (id)
KR (1)	KR100322354B1 (id)
CN (2)	CN1238454A (id)
AP (3)	AP9901481A0 (id)
AR (1)	AR014074A1 (id)
AT (1)	ATE218552T1 (id)
AU (1)	AU2031999A (id)
BR (1)	BR9900984A (id)
CA (1)	CA2265194C (id)
DE (1)	DE69901656T2 (id)
DK (1)	DK0963980T3 (id)
EA (1)	EA000666B1 (id)
ES (1)	ES2178342T3 (id)
GB (1)	GB9812413D0 (id)
HR (1)	HRP990074A2 (id)
HU (1)	HUP9900592A3 (id)
ID (1)	ID22957A (id)
MA (1)	MA24777A1 (id)
NO (2)	NO991151L (id)
NZ (1)	NZ334590A (id)
PE (1)	PE20000332A1 (id)
PL (1)	PL331870A1 (id)
PT (1)	PT963980E (id)
SG (1)	SG85628A1 (id)
SI (1)	SI0963980T1 (id)
TR (1)	TR199900520A3 (id)
UY (1)	UY25946A1 (id)
YU (1)	YU12399A (id)
ZA (1)	ZA991951B (id)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020055177A1 (en) *	1999-03-10	2002-05-09	Glaxo Wellcome Inc.	Compound and its use
WO2001049669A1 (en) *	2000-01-03	2001-07-12	Rpg Life Sciences Limited	A process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
WO2002053540A1 (en)	2000-12-29	2002-07-11	Pfizer Limited	Aspartate derivative of amlodipine as calcium channel antagonist
IL156692A0 (en)	2000-12-29	2004-01-04	Pfizer Ltd	Process for making amlodipine maleate
WO2002053541A1 (en)	2000-12-29	2002-07-11	Pfizer Limited	Amide derivative of amlodipine
MXPA03005882A (es)	2000-12-29	2005-04-19	Pfizer Ltd	Derivado amida de amlodipina.
EP1309556B1 (en)	2000-12-29	2004-11-24	Pfizer Limited	Amlodipine fumarate
AT5874U1 (de)	2000-12-29	2003-01-27	Bioorg Bv	Pharmazeutische zubereitungen enthaltend amlodipinmaleat
US7335380B2 (en)	2000-12-29	2008-02-26	Synthon Ip Inc.	Amlodipine free base
US6653481B2 (en)	2000-12-29	2003-11-25	Synthon Bv	Process for making amlodipine
DE60116514T2 (de)	2000-12-29	2006-08-17	Pfizer Ltd., Sandwich	Amlodipinhemimaleat
GB2371862B (en)	2000-12-29	2004-07-14	Bioorg Bv	Reference standards for determining the purity or stability of amlodipine maleate and processes therefor
DE10134980C2 (de)	2001-07-17	2003-05-28	Helm Ag	Verfahren zur Herstellung von Lamotrigin
CA2366521C (en)	2001-12-24	2007-03-06	Brantford Chemicals Inc.	A new and efficient process for the preparation of lamotrigine and related 3,5-diamino-6-substituted-1,2,4-triazines
CA2479668A1 (en) *	2002-03-20	2003-10-02	Teva Pharmaceutical Industries Ltd.	Crystalline forms of quetiapine hemifumarate
HU225667B1 (en) *	2002-09-20	2007-05-29	Richter Gedeon Nyrt	Method for producing high-purity 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
ES2209639B1 (es)	2002-10-31	2005-08-01	Vita Cientifica, S.L.	Procedimiento para la obtencion de un compuesto farmaceuticamente activo y obtencion de su intermedio.
GB2395483A (en) *	2003-07-03	2004-05-26	Jubilant Organosys Ltd	Crystalline lamotrigine and its monohydrate
EP1562912A2 (en)	2003-08-28	2005-08-17	Teva Pharmaceutical Industries Limited	Process for preparation of rosuvastatin calcium
US7777034B2 (en) *	2003-11-24	2010-08-17	Teva Pharmaceutical Industries Ltd.	Crystalline ammonium salts of rosuvastatin
WO2005056534A1 (en) *	2003-12-02	2005-06-23	Teva Pharmaceutical Industries Ltd.	Reference standard for characterization of rosuvastatin
US7851624B2 (en) *	2003-12-24	2010-12-14	Teva Pharamaceutical Industries Ltd.	Triol form of rosuvastatin and synthesis of rosuvastatin
WO2005075427A2 (en) *	2004-01-30	2005-08-18	Teva Pharmaceutical Industries Ltd.	Montelukast sodium polymorphs
US20050187243A1 (en) *	2004-01-30	2005-08-25	Valerie Niddam-Hildesheim	Montelukast free acid polymorphs
MD2823G2 (ro) *	2004-02-12	2006-05-31	Институт Химии Академии Наук Молдовы	Procedeu de determinare cantitativă a sclareolului în extractele, obţinute din salvia de muscat
CA2563776A1 (en) *	2004-04-21	2005-11-10	Teva Pharmaceutical Industries Ltd.	Processes for preparing montelukast sodium
WO2005105768A2 (en) *	2004-04-26	2005-11-10	Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg	Process for preparation of mycophenolic acid and ester derivatives thereof
US20050250773A1 (en)	2004-04-27	2005-11-10	Sandor Molnar	Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
DK1761478T3 (da) *	2004-06-28	2008-12-15	Teva Pharm Fine Chemicals Srl	En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder
US7439399B2 (en) *	2004-06-28	2008-10-21	Teva Pharmaceutical Fine Chemicals	Processes for the preparation of atomoxetine hydrochloride
WO2006017357A1 (en) *	2004-07-13	2006-02-16	Teva Pharmaceutical Industries Ltd.	A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step
DE602005020014D1 (de) *	2004-07-20	2010-04-29	Teva Gyogyszergyar Zartkoeruen	Kristallines mycophenolat-natrium
CN1976894A (zh) *	2004-07-22	2007-06-06	特瓦药物精化学品股份有限公司	阿托莫西汀盐酸盐的多形体
WO2006029253A2 (en) *	2004-09-04	2006-03-16	Teva Pharmaceutical Industries Ltd.	A valacyclovir impurity, process for the preparation of valacyclovir impurity and use as a reference standard
US20060081361A1 (en) *	2004-09-13	2006-04-20	Gabbey Lawrence W	Oil cooler with integral filter
TW200825092A (en) *	2004-09-28	2008-06-16	Teva Pharma	A method for reducing the level of AED in atorvastatin calcium sample
US20060128788A1 (en) *	2004-10-19	2006-06-15	Santiago Ini	Purification of tegaserod maleate
US7678551B2 (en) *	2004-10-25	2010-03-16	Seradyn, Inc.	Immunoassays for lamotrigine
JP2007523213A (ja) *	2004-12-23	2007-08-16	テバファーマシューティカルインダストリーズリミティド	医薬的に許容できるデュロキセチンの塩及びその中間体の調製方法
CA2591487A1 (en) *	2005-01-11	2006-07-20	Teva Pharmaceutical Fine Chemicals S.R.L.	Polymorphs of memantine hydrochloride
KR100945763B1 (ko) *	2005-02-22	2010-03-08	테바 파마슈티컬 인더스트리즈 리미티드	로수바스타틴의 제조 방법
US20070167625A1 (en) *	2005-02-22	2007-07-19	Anna Balanov	Preparation of rosuvastatin
US20070037979A1 (en) *	2005-02-22	2007-02-15	Valerie Niddam-Hildesheim	Preparation of rosuvastatin
US7291614B2 (en)	2005-02-24	2007-11-06	Teva Pharmaceutical Industries Ltd.	Processes for the preparation of linezolid intermediate
TW200639161A (en) *	2005-03-14	2006-11-16	Teva Pharma	Process for the purification of duloxetine hydrochloride
MX2007010268A (es) *	2005-04-05	2008-02-19	Teva Pharm Fine Chemicals Srl	Clorhidrato de atomoxetina estable, un proceso para la preparacion del mismo, y un control analitico de su estabilidad.
CA2603129A1 (en) *	2005-04-06	2006-10-12	Teva Pharmaceutical Industries Ltd.	Crystalline forms of pregabalin
US7488846B2 (en) *	2005-04-11	2009-02-10	Teva Pharmaceuical Industries Ltd.	Pregabalin free of lactam and a process for preparation thereof
US20070066846A1 (en) *	2005-04-11	2007-03-22	Asher Maymon	Process for making (S)-Pregabalin
JP2008502707A (ja) *	2005-04-14	2008-01-31	テバファーマシューティカルインダストリーズリミティド	クエチアピンフマレートの調製方法
US20080281111A1 (en) *	2005-04-26	2008-11-13	Sandor Molnar	Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
EP1879852A1 (en) *	2005-05-10	2008-01-23	Teva Pharmaceutical Industries Ltd	Pregabalin free of lactam and a process for preparation thereof
BRPI0605833A (pt) *	2005-05-10	2007-12-18	Teva Pharma	pregabalina livre de ácido isobutilglutárico e um processo para sua preparação
CA2604602A1 (en) *	2005-05-10	2006-11-16	Teva Pharmaceutical Industries Ltd.	Method for the preparation of pregabalin and salts thereof
MX2007014129A (es) *	2005-05-10	2008-01-11	Teva Pharma	Resolucion optica del acido 3-carbamoilmetil-5-metil hexanoico.
WO2006127933A1 (en)	2005-05-23	2006-11-30	Teva Pharmaceutical Industries Ltd.	Processes for preparing cinacalcet hydrochloride crystal form i
CN101233100A (zh) *	2005-06-27	2008-07-30	西科尔公司	阿那曲唑中间体的杂质及其应用
WO2007002720A2 (en) *	2005-06-27	2007-01-04	Sicor, Inc.	An impurity of anastrozole intermediate, and uses thereof
WO2007005965A1 (en) *	2005-07-05	2007-01-11	Teva Paharmaceutical Industries Ltd.	Purification of montelukast
EP1805148A2 (en) *	2005-08-16	2007-07-11	Teva Pharmaceutical Industries Ltd.	Crystalline rosuvastatin intermediate
US7446220B2 (en) *	2005-09-19	2008-11-04	Teva Pharmaceutical Industries Ltd.	Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
US20070197529A1 (en) *	2005-12-01	2007-08-23	Viviana Braude	Isolated desfluoro-linezolid, preparation thereof and its use as a reference marker and standard
WO2007067581A1 (en)	2005-12-05	2007-06-14	Teva Pharmaceutical Industries Ltd.	2-(n-methyl-propanamine)-3-(2-naphthol) thiophene, an impurity of duloxetine hydrochloride
WO2007069264A2 (en) *	2005-12-15	2007-06-21	Alembic Limited	Reference standards for determining the purity of telithromycin and processes therefor
US20070203221A1 (en) *	2005-12-27	2007-08-30	Valeriano Merli	Processes for preparing darifenacin hydrobromide
WO2007126886A1 (en) *	2006-03-27	2007-11-08	Teva Pharmaceuticals Usa, Inc.	Process for preparing memantine hydrochloride substantially free of impurities
US20080146675A1 (en) *	2006-04-05	2008-06-19	Eugenio Castelli	Stable Atomoxetine Hydrochloride, a process for the preparation thereof, and an analytical control of its stability
GB0609835D0 (en) *	2006-05-18	2006-06-28	Pliva Istrazivanje I Razvoj D	Impurities of a pharmaceutical product
WO2007139933A2 (en) *	2006-05-24	2007-12-06	Teva Pharmaceutical Industries Ltd.	Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof
BRPI0702897A2 (pt) *	2006-05-31	2011-03-15	Teva Pharmaceutical Ind Ltda	processo para preparar um intermediário de pregabalina
WO2007143152A2 (en) *	2006-05-31	2007-12-13	Teva Pharmaceutical Industries Ltd.	Preparation of (s)-pregabalin-nitrile
WO2008002665A1 (en) *	2006-06-29	2008-01-03	Teva Pharmaceutical Industries Ltd.	Regulation of acid metabolite production
US20120142919A1 (en) *	2006-08-02	2012-06-07	Medichem, S.A.	Method for synthesizing lamotrigine
CN101506178A (zh) *	2006-08-14	2009-08-12	隆沙有限公司	制备拉莫三嗪的方法
US20080242877A1 (en) *	2007-02-26	2008-10-02	Vinod Kumar Kansal	Intermediates and processes for the synthesis of Ramelteon
WO2008118427A2 (en) *	2007-03-22	2008-10-02	Teva Pharmaceutical Industries Ltd.	Synthesis of (s)-(+)-3-(aminomethyl)-5-methyl hexanoic acid
BRPI0803097A2 (pt) *	2007-04-11	2011-11-08	Teva Gyogyszergyar ...	método para redução do nìvel de impurezas na fermentação do ácido micofenólico
WO2008151170A2 (en) *	2007-05-31	2008-12-11	Teva Pharmaceutical Industries Ltd.	Process for the synthesis of ramelteon and its intermediates
KR20090101462A (ko) *	2007-10-03	2009-09-28	테바 파마슈티컬 인더스트리즈 리미티드	프레가발린-4-엘리미네이트, 프레가발린 5-엘리미네이트, 기준 마커 및 표준물로서의 이들의 용도, 및 이들을 낮은 수준으로 함유하는 프레가발린의 제조 방법
KR20100058660A (ko) *	2007-10-23	2010-06-03	테바 파마슈티컬 인더스트리즈 리미티드	다사티닙 다형체 및 이의 제조 방법
WO2009056993A2 (en) *	2007-11-01	2009-05-07	Teva Pharmaceutical Industries Ltd.	A process for the synthesis of ramelteon and its intermediates
WO2009061513A1 (en) *	2007-11-09	2009-05-14	Thar Pharmaceuticals	Crystalline forms of lamotrigine
CA2717580A1 (en) *	2008-03-06	2009-12-17	Teva Pharmaceutical Industries Ltd.	Processes for the preparation of o-desmethylvenlafaxine, free from its dimer impurities
KR20100107500A (ko) *	2008-06-23	2010-10-05	테바 파마슈티컬 인더스트리즈 리미티드	(ｓ) 또는 (ｒ)-이소-부틸-글루타릭 에스테르의 입체선택적 효소 합성방법
US20100152468A1 (en) *	2008-10-16	2010-06-17	Teva Pharmaceutical Industries Ltd.	Process for the synthesis of ramelteon and its intermediates
EP2539313A2 (en) *	2010-03-29	2013-01-02	Pliva Hrvatska D.O.O.	Crystal forms of o-desmethylvenlafaxine fumarate
WO2012034065A1 (en)	2010-09-09	2012-03-15	Teva Pharmaceutical Industries Ltd.	Aliskiren intermediates and a process for analyzing the purity of aliskiren
CN102766104A (zh) *	2012-08-20	2012-11-07	三金集团湖南三金制药有限责任公司	一种治疗双向情感障碍及癫痫病药物拉莫三嗪的合成方法
US10189859B2 (en)	2013-12-21	2019-01-29	Nektar Therapeutics	Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine
CN110467560B (zh)	2018-05-09	2025-11-25	深圳微芯生物科技股份有限公司	一种苯基氨基丙酸钠衍生物、其制备方法和应用
KR102270026B1 (ko) *	2020-01-31	2021-06-28	현대약품 주식회사	(3s)-3-(4-(3-(1,4-다이옥사스파이로[4,5]데스-7-엔-8-일)벤질옥시)페닐)헥스-4-이노익산의 품질 평가 방법
CN113156009B (zh) *	2021-04-20	2023-12-22	三金集团湖南三金制药有限责任公司	高效液相色谱分析拉莫三嗪的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL124029B1 (en)	1979-06-01	1982-12-31	Wellcome Found	Process for preparing novel derivatives of 1,2,4-triazine
DE3062603D1 (en)	1979-06-01	1983-05-11	Wellcome Found	3,5-diamino-1,2,4-triazine derivatives, process for preparing such compounds and pharmaceutical compositions containing them
GB8613183D0 (en)	1986-05-30	1986-07-02	Wellcome Found	Triazine salt
GB9426448D0 (en) *	1994-12-30	1995-03-01	Wellcome Found	Process
AU4311596A (en) *	1994-12-30	1996-07-24	Wellcome Foundation Limited, The	Process for the preparation of lamotrigine
GB9512854D0 (en) *	1995-06-23	1995-08-23	Wellcome Found	Novel formulation

1998
- 1998-06-10 GB GBGB9812413.4A patent/GB9812413D0/en not_active Ceased
1999
- 1999-02-24 EA EA199900159A patent/EA000666B1/ru not_active IP Right Cessation
- 1999-02-25 SG SG9901252A patent/SG85628A1/en unknown
- 1999-03-09 KR KR1019990007632A patent/KR100322354B1/ko not_active Expired - Fee Related
- 1999-03-09 HR HR990074A patent/HRP990074A2/hr not_active Application Discontinuation
- 1999-03-10 PE PE1999000190A patent/PE20000332A1/es not_active Application Discontinuation
- 1999-03-10 DK DK99200695T patent/DK0963980T3/da active
- 1999-03-10 ES ES99200695T patent/ES2178342T3/es not_active Expired - Lifetime
- 1999-03-10 HU HU9900592A patent/HUP9900592A3/hu unknown
- 1999-03-10 ID IDP990201D patent/ID22957A/id unknown
- 1999-03-10 EP EP99200695A patent/EP0963980B1/en not_active Expired - Lifetime
- 1999-03-10 BR BR9900984-6A patent/BR9900984A/pt not_active IP Right Cessation
- 1999-03-10 YU YU12399A patent/YU12399A/sh unknown
- 1999-03-10 TR TR1999/00520A patent/TR199900520A3/tr unknown
- 1999-03-10 SI SI9930088T patent/SI0963980T1/xx unknown
- 1999-03-10 AT AT99200695T patent/ATE218552T1/de not_active IP Right Cessation
- 1999-03-10 AP APAP/P/1999/001481A patent/AP9901481A0/en unknown
- 1999-03-10 PL PL99331870A patent/PL331870A1/xx not_active Application Discontinuation
- 1999-03-10 EP EP01203376A patent/EP1170588A1/en not_active Withdrawn
- 1999-03-10 DE DE69901656T patent/DE69901656T2/de not_active Expired - Fee Related
- 1999-03-10 CN CN99103445A patent/CN1238454A/zh active Pending
- 1999-03-10 PT PT99200695T patent/PT963980E/pt unknown
- 1999-03-10 JP JP11063792A patent/JP2989189B1/ja not_active Expired - Fee Related
- 1999-03-10 CA CA002265194A patent/CA2265194C/en not_active Expired - Fee Related
- 1999-03-10 NZ NZ334590A patent/NZ334590A/xx unknown
- 1999-03-10 MA MA25489A patent/MA24777A1/fr unknown
- 1999-03-10 US US09/265,670 patent/US6333198B1/en not_active Expired - Fee Related
- 1999-03-10 AR ARP990101018A patent/AR014074A1/es not_active Application Discontinuation
- 1999-03-10 NO NO991151A patent/NO991151L/no unknown
- 1999-03-10 AU AU20319/99A patent/AU2031999A/en not_active Abandoned
- 1999-03-10 ZA ZA9901951A patent/ZA991951B/xx unknown
- 1999-03-10 AP APAP/P/2001/002286A patent/AP0102286A0/en unknown
2000
- 2000-01-17 UY UY25946A patent/UY25946A1/es unknown
- 2000-07-25 CN CN00122208A patent/CN1306210A/zh active Pending
2001
- 2001-09-06 AP AP2001002286A patent/AP2001002286A0/xx unknown
2003
- 2003-06-17 NO NO20032753A patent/NO20032753D0/no unknown

Also Published As

Publication number	Publication date
JP2000009714A (ja)	2000-01-14
ATE218552T1 (de)	2002-06-15
BR9900984A (pt)	2000-05-02
JP2989189B1 (ja)	1999-12-13
EP0963980A2 (en)	1999-12-15
EP0963980B1 (en)	2002-06-05
EP0963980A3 (en)	2000-05-31
HUP9900592A3 (en)	2002-04-29
YU12399A (sh)	2002-08-12
KR100322354B1 (ko)	2002-02-07
AP2001002286A0 (en)	2001-12-31
MA24777A1 (fr)	1999-10-01
KR20000005611A (ko)	2000-01-25
CA2265194C (en)	2000-10-10
US6333198B1 (en)	2001-12-25
TR199900520A2 (en)	2000-01-21
HRP990074A2 (en)	2000-10-31
CN1238454A (zh)	1999-12-15
PE20000332A1 (es)	2000-04-10
HUP9900592A2 (hu)	2000-04-28
NZ334590A (en)	2000-07-28
PT963980E (pt)	2002-10-31
ES2178342T3 (es)	2002-12-16
SI0963980T1 (en)	2002-12-31
EA000666B1 (ru)	2000-02-28
DK0963980T3 (da)	2002-09-16
NO991151L (no)	1999-12-13
UY25946A1 (es)	2000-12-29
AP0102286A0 (en)	2000-09-10
SG85628A1 (en)	2002-01-15
DE69901656T2 (de)	2003-01-30
AU2031999A (en)	2000-01-06
AR014074A1 (es)	2001-01-31
NO991151D0 (no)	1999-03-10
HU9900592D0 (en)	1999-04-28
EA199900159A1 (ru)	1999-12-29
TR199900520A3 (tr)	2000-01-21
GB9812413D0 (en)	1998-08-05
EP1170588A1 (en)	2002-01-09
NO20032753D0 (no)	2003-06-17
PL331870A1 (en)	1999-12-20
NO20032753L (no)	1999-12-13
ZA991951B (en)	1999-08-16
DE69901656D1 (de)	2002-07-11
AP9901481A0 (en)	1999-03-31
CN1306210A (zh)	2001-08-01

Publication	Publication Date	Title
ID22957A (id)	1999-12-23	Senyawa dan penggunaannya
ID29591A (id)	2001-09-06	Senyawa-senyawa kuinolina dan kuinoksalina
ID23575A (id)	2000-05-04	Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID22889A (id)	1999-12-16	Komposisi kopolimer etilena dan penggunaannya
ID24839A (id)	2000-08-24	Senyawa-senyawa triazol dan penggunaannya
ID28787A (id)	2001-07-05	2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya
ID24196A (id)	2000-07-13	Komposisi dan penggunaan
ID28990A (id)	2001-07-19	Herbisida-herbisida dengan urea aminofenilsulfonil asilasi
ID19422A (id)	1998-07-09	Piridina dan bifenil tersubstitusi
ID24148A (id)	2000-07-13	Turunan-turunan fitostfrol dan/atau fitostanol
ID25977A (id)	2000-11-16	Popok sekali pakai
ID24555A (id)	2000-07-27	Popok sekali pakai
ID23076A (id)	2000-02-03	Popok sekali pakai
ID26848A (id)	2001-02-15	Koupling untuk gigi-gigi eksapator dan sejenisnya
ID19824A (id)	1998-08-06	Turunan-turunan ditiolan, pembuatannya dan pengaruh terapinya
NO20001830D0 (no)	2000-04-07	Ny kombinasjon
ID28846A (id)	2001-07-05	2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya
NO20005503L (no)	2001-01-04	Ny anvendelse
ID29943A (id)	2001-10-25	Senyawa dds dan metode pengukurannya
ID26599A (id)	2001-01-25	Turunan triazola dan imidazola
ID22956A (id)	1999-12-23	Sintesa disulfida dan polisulfida organik
ID27480A (id)	2001-04-12	Pembungkusan berstruktur dan elemennya
ID23083A (id)	2000-02-03	Popok sekali pakai
ID28752A (id)	2001-06-28	Metode-metode dan komposisi-komposisi sanitasi
ID16889A (id)	1997-11-20	Senyawa turunan alkilaminobenzotiazol dan benzoksazol